Phase 2 randomised study of bulevirtide as monotherapy or combined with Peg-IFNα-2a as treatment for chronic hepatitis delta
by Lampertico, Pietro (Author)
, Bogomolov, Pavel O. (Author)
, Chulanov, Vladimir (Author)
, Stepanova, Tatiana (Author)
, Morozov, Viacheslav (Author)
, Allweiss, Lena (Author)
, Dandri, Maura (Author)
, Burhenne, Jürgen (Author)
, Blank, Antje (Author)
, Ciesek, Sandra (Author)
, Elsner, Carina (Author)
, Dittmer, Ulf (Author)
, An, Qi (Author)
, Manuilov, Dmitry (Author)
, Da, Ben L. (Author)
, Flaherty, John F. (Author)
, Urban, Stephan (Author)
, Wedemeyer, Heiner (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource